Page 15 - FBL AR 2019-20

Corporate Statutory FinanCial
overview StatementS StatementS

Ms. Rajashri Ojha Mr. Krishna Datla Mr. Satish Varma Ms. Anupama Datla
Non-Executive Managing Director Executive Director Desai
Independent Director Executive Director

Has over three decades He has played a key role in the He joined FBL group (formerly She has been appointed as
of experience in the decision making process and known as DIL group) as the an additional director in the
pharmaceutical, medical also oversees new businesses Executive Assistant to the then Company and thereafter as an
devices and nutraceutical of the Company. Mr. Krishna Managing Director in 1995 Executive Director for a period
industries with an exposure Datla is also the Promoter and rose to the position of of three years with effect from
in the R&D analytical Director of Fermenta Biotech Executive Director in 2003. In September 27, 2019. She has
development, formulations Limited (Formerly known as this role he garnered extensive an experience over 13 years
development, regulatory DIL Limited). Credited with operational, management and in various areas of business
& QA compliance, global the integration of businesses legal experience across the full activities and in addition to
registrations and marketing across the various group scope of the Company. Highly her R&D responsibilities; she
approvals. She is a Lead companies, he has infused enterprising and analytical, he is also responsible for quality
Auditor for ISO 13485:2016 and a strong sense of global has led the charge on various control and implementation of
ISO 9001:2015. A founder and vision thereby opening important projects. safety policies and procedures,
Director of Raaj Gprac Private the opportunities across implementation of new
Ltd. Working as Lead Auditor, International markets. technology platforms, business
Global RA and GMP consultant development, customer
and trainer. She was associated interaction and marketing.
with leading pharma and Ms. Anupama worked for
medical device companies in erstwhile Fermenta Biotech
training industry professionals. Limited since 2006 and
She authored articles and under her guidance erstwhile
research papers in reputed Fermenta Biotech Limited
national and international had evolved from a simple
journals. She was awarded bulk drug manufacturer, into
Healthcare Leadership Awards a discovery and development
and Women Leadership based, specialised and diverse
Awards. She was a guest biotechnology Company
speaker at KLE University, engaged in novel discovery,
NIPER, NMIMS, BCP, MET, JSS, formulation and process
HKCP, BNCP and a member of development platforms.
DIA, IPA, TOPRA, RAPs, IDMA,
QCI, NSDC, IBSC, AMTZ and
AIMED etc.

13